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Abstract.  Growth-associated protein 43 (GAP-43) is 
an abundant,  intensely investigated membrane phos- 
phoprotein of the nervous system (Benowitz, L.  I., 
and A.  Routtenberg.  1987.  Trends Neurosci. 
10:527-532;  Skene, J.  H. P.  1989. Annu.  Rev. Neu- 
rosci.  12:127-156),  with a hitherto unknown function. 
We have previously demonstrated that astrocytes, brain 
macroglial cells, contain GAP-43 (Steisslinger,  H. W., 
V. J.  Aloyo, and L.  Vitkovi6.  1987. Brain Res. 
415:375-379;  Vitkovi6, L., H. W. Steisslinger,  V. J. 
Aloyo, and M.  Mersel.  1988. Proc. Natl.  Acad. Sci. 
USA. 85:8296-8300;  Vitkovi6,  L., and M.  Mersel. 
1989.  Metab. Brain Dis.  4:47-53).  Results from dou- 
ble immunofluorescent labeling experiments presented 
here show that oligodendrocytes also contain GAP-43 
immunoreactivity (GAP-43ir).  Thus,  all three macro- 
glial cell types of the central nervous system (type 1 
and type 2 astrocytes and oligodendrocytes) contain 
GAP-43.  Whereas immunoreactive GAP-43 is ex- 
pressed by progenitors of all macroglial cell types, the 
developmental regulation of its expression is cell type 
specific. Immunoreactive GAP-43 is downregulated in 
type 1 astrocytes, and constitutively expressed in both 
type 2 astrocytes and oligodendrocytes. These results 
may be relevant to potential function(s) of GAP-43. 
gowTH-associated protein-43  (GAP-43) ~ is an abun- 
dant,  membrane-bound phosphoprotein present in 
the central nervous system of many species. The ex- 
pression of this protein is dramatically elevated during devel- 
opment and regeneration  (Jacobsen et al., 1986; Basi et al., 
1987; Benowitz and Routtenberg,  1987; Skene, 1989). GAP- 
43 appears to play a role in synaptic  plasticity  underlying 
memory and  learning  (Benowitz  and  Routtenberg,  1987; 
Snipes et al., 1987), although its precise function in this pro- 
cess remains poorly understood. GAP-43 does not appear to 
be exclusively expressed in neurons, as previously suggested 
(Benowitz  and Routtenberg,  1987; Benowitz  et al.,  1988; 
Goslin  et  al.,  1988).  Recent  evidence  based  on  elec- 
trophoretic,  chemical and antigenic properties,  indicate that 
GAP-43 is also present in rat cortical astrocytes (Steisslinger 
et al.,  1987; Vitkovi6  et al.,  1988;  Vitkovi6 and Mersel, 
1989).  Astrocytes, together with oligodendrocytes,  consti- 
tute the two major macroglial  cell types in the vertebrate 
CNS (Miller et al.,  1989).  Two morphologically and anti- 
genically distinct types of astrocytes, type 1 and 2, have been 
characterized in dissociated cell suspensions  of rat embry- 
onic and postnatal brain (Abney et al., 1981) and optic nerve 
(Raft, 1989; Williams et al., 1985). Immunostaining  and sil- 
ver impregnation  of the optic nerve suggest that these two 
kinds of macroglial  cells exist in vivo (Miller et al.,  1989). 
1. Abbreviations used in this paper: GAP-43, growth-associated protein-43; 
GFAP,  glial  fibrillary acidic protein. 
Whether type-1 and 2 astrocytes in the cortex (Miller and 
Raft,  1984) correspond to protoplasmic and fibrous astro- 
cytes, respectively,  (Williams et al.,  1985) remains  unclear 
(Miller et al.,  1989). The three types of macroglia,  type 1 
astrocytes,  type 2 astrocytes and oligodendrocytes,  can be 
distinguished  in cultures of embryonic rat brain, where, re- 
markably, the cells develop on the same schedule as in vivo 
(Abney et al., 1981; Wdliams et al., 1985). Some distinguish- 
ing properties of the three major types of macroglia have 
been summarized in recent reviews (Miller et ai., 1989; Raft, 
1989). We are investigating the regulation  of GAP-43 gene 
expression to elucidate the role of this phosphoprotein in CNS 
function.  Here, we report results on the developmental  ex- 
pression of GAP-43ir in primary cultures of rat cortical mac- 
roglia,  which demonstrate that all three known macroglial 
cell types and their progenitors express  GAP-43ir. Our re- 
suits further show that the regulation  of macroglial  GAP-43 
is cell type-specific in that type 1 astrocytes downregulate  it 
and type 2 astrocytes and oligodendrocytes appear to express 
it constitutively. 
Materials and Methods 
Astrocyte Cultures 
Brain  cortices removed from  1-d-old  Sprague-Dawley  rats  served as  a 
source of the macroglial cells. Astrocyte cultures were prepared as previ- 
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and Mersel,  1989).  Briefly,  1-d-old Sprague-Dawley  rat newborns were 
decapitated  and their brain hemispheres were removed.  The hemispheres, 
freed of meninges, were soaked in glntamine-free DME with 50 U/ml peni- 
cillin, 50 #g/rni streptomycin,  and 20% FCS, gently dissociated mechani- 
cally by pipetting,  and filtered through 80-#m nylon mesh (Nytex;  Tetko, 
NJ). The resulting dispersed cells were seeded at a density of 1-2  x  104 
cells per cm  z,  on  13-mm-wide glass coverslips  that had been precoated 
with poly-L-lysine at 3 #g per cm: (Sigma Chemical Co., St. Louis,  MO), 
for 15 min. The medium consisted of glutamine-free DME with 50 U/ml 
penicillin, 50 ~g/ml streptomycin  and 20% FCS (Hazelton,  St.  Lenexa, 
KS). After first 3 d of seeding,  the percent FCS in the above medium was 
lowered to 10%.  The medium was changed every 2 d. 
Enriched Oligodendrocyte Cultures 
Oligodendrocytes  were  prepared by modifying the published method of 
Dubois-Dalcq et al. (1986).  1-d-old Sprague-Dawley  rat cortices were dis- 
sected,  meninges were removed, and tissue was triturated 10 times through 
a 10-gange needle, and passed through an 80-#m Nytex nylon mesh. Cells 
derived from four cortices and suspended in 10 ml of medium (DME con- 
taining 20% FCS,  50 U/mi penicillin, and 50 ug/ml  streptomycin)  were 
seeded in 75-cm  2 plastic flasks (Costar Corp., Cambridge, MA) at 1.2 to 
2.4  x  lO  s cells per cm  2. After 3 d incubation at 37°C,  the cultures were 
shaken on a rotary shaker at 100 rpm for 1 h at room temperature.  The 
medium containing oligodendrocytic  progenitors was  removed  and cen- 
trifuged at 77 g for 5 rain. The cells were resuspended in the medium de- 
scribed above but containing 10% FCS and replated at the initial density 
in one 75-cm  2 plastic flask.  Cells were grown for another 3 d and then 
shaken overnight at 37°C at 100 rpm. Nonattached cells were harvested as 
described above and suspended in glutamine-free DME with 25 t~g/ml gen- 
tamycin and 4.5 g/liter glucose enriched in 2 mM glutamine, 50 #g/ml 
transferrin, 5/~g/ml insulin, 30 nM selenium, 30 nM triiodothyronine (Ec- 
cleston and Silberberg,  1984). To this basic medium we added 0.5% FCS 
as recommended by Dubois-Dalcq et al. 0986) to facilitate the early adhe- 
sion and growth of progenitors.  The resulting dispersed cells were seeded 
at a density of lOs cells per cm  2, on 13-mm wide glass coverslips  which 
had been precoated with 3 izg/cm  2 poly-L-lysine as described above. 
Neuron Cultures 
Primary cultures of rat cerebeilar granule neurons were prepared as previ- 
ously described (Yovelli et al.,  1988) and provided by R. C. Henneberry 
(National  Institute of Neurological  Disorders and Stroke  [NINDS],  Na- 
tional Institutes of Health). 
Purification of GAP-43 
GAP-43 was isolated from 8-d-old rat brain by alkaline extraction, ammo- 
nium sulphate precipitation and isoelectric  focusing (IEE Sephadex G-200 
flat bed), as previously  described (Oestreicher et al.,  1983). IEF-derived 
fractions were passed through mixed bed AG 501 X8 resin to remove am- 
pholines and provided to us by V. J. Aloyo (Medical College of Pennsylva- 
nia, Philadelphia). We resolved the proteins in GAP-43-enriched  fraction 
by preparative SDS-PAGE using 10-20% gradient gels (Integrated Separa- 
tion  Systems,  Hyde  Park,  MA).  The  band corresponding to  GAP-43, 
identified  by Western blotting, was excised and electrophoretically  eluted 
using the Elutrap (Schleicher &  Schuell,  Kcene,  NH) according to the 
manufacturer's instructions. Protein recoveries  were estimated using the 
Bio-Rad protein assay (Bio-Rad  Laboratories, Richmond, CA). 
Fixation and lmmunolabeling 
Individual macroglial cell types were identified by double immunolabeling 
of cells in culture with antibodies described below. Cells were incubated at 
room temperature in 40-50 #1 of each antibody solution for 30 min, fol- 
lowed  by  an  incubation in the  appropriate  rhodamine- or  fluorescein- 
conjugated  second antibody solution. Antibodies were  diluted in DME 
(Whittaker Bioproducts,  Walkersville, MD), containing 0.02 M Hepes and 
10% FCS.  After every incubation, cells were washed several times with 
DME containing 0.02 M Hopes. Surface antigens rat neural antigen-2 (Ran-2), 
A2B5, and galactocerebroside (GC) were visualized on living cells (Wol- 
swijk and Noble, 1989). Intracellular antigens glial fibrillary acidic protein 
(GFAP) and neurofilament  protein, NF-68, were detected after fixation in 
methanol at -20°C for 10 rain (Wolswijk and Noble, 1989). The membrane 
associated  antigen GAP-43 was detected after both, fixation in methanol at 
-20°C for 10 min followed by permeabilization with 0.01% (wt/vol) digito- 
nin for 30 rain and direct exposure to primary antibody (Vitkovi6 et al., 
1988).  Cells were irnmunolabeled with a combination of the following: 
mouse IgM A2B5 monoclonal  antibody obtained from M. Dubois-Dalcq 
(NINDS,  NIH) (ascites,  1:100 or fresh, undiluted hybridoma supernatant; 
Eisenbarth et al., 1979), mouse IgM Ran-2 (fresh, undiluted hybridoma su- 
pernatant; Bartlett et al., 1981), mouse IgG anti-GC monoclonal antibody 
(hybridoma supernatant, 1:10, Ranscht et al. 1982), polyclonal rabbit anti- 
GFAP antiserum (obtained from R. Lipsky,  NINDS,  NIH) (1:500; Temple 
and Raft,  1985),  mouse IgG monoclonal antineumfilament 68 kD (undi- 
luted,  Boehringer-Mannheim Biochemicals,  Indianapolis,  IN).  Two poly- 
clonal antibodies against rat GAP-43 were used:  a rabbit serum obtained 
from G. J. Snipes and J. A. Freeman (Vanderbilt University School of Medi- 
cine; Skene et al.,  1986) was partially purified by adsorbing out the IgGs 
specific to cortical plasma membrane proteins other than GAP-43 (Vitkovi6 
et al., 1988). An affinity-purified anti-GAP-43 antibody raised in sheep was 
from L. I. Benowitz  (Mailman Research  Center,  McLean Hospital, Bel- 
mont, MA; Benowitz et al., 1988). The binding of A2B5 or Ran-2 antibod- 
ies was detect~l with fluorescein- or rhodamine-conjugated  secondary ami- 
bodies.  The fluorescein  detection method used donkey  anti-mouse IgG, 
biotinylated species-specific  F(alY)2 fragment (1:200;  Amersham Corp., 
Arlington Heights, IL), followed by streptavidin-FITC  (1:200, Amersham). 
The rhodamine detection method used goat anti-mouse IgG lissamine rho- 
damine conjugate (1:1,000; Bochringar-Mannbeim Biochemicals). The bind- 
ing of rabbit anti-GFAP  was  detected  with donkey  anti-rabbit IgG,  bio- 
tinylated  species-specific  F(alY)2 fragment  (1:200;  Amersham  Corp.), 
followed by streptavidin-FITC  (1:200; Amersham  Corp.) or goat anti-rabbit 
IgG lissamine rhodamine conjugate  (1:1,000; Boehringer-Mannheim Bio- 
chemicals).  The binding of mouse anti-NF-68 was detected with goat anti- 
mouse IgG lissamine rhodamine conjugate (1:1,000; Bochringer-Mannbeim 
Biochemicals).  The binding of rabbit anti-GAP-43 was detected with don- 
key anti-rabbit IgG, biotinylated species-specific  F(alY)2 fragment (1:200; 
Amersham Corp.) followed by streptavidin-FITC  (1:200; Amersham Corp.) 
or ABC-phycoerythrin (Vector Laboratories, Burlingame,  CA) according 
to the manufacturer's  instructions. In some experiments,  goat anti-rabbit 
IgG lissamine rhndamine conjugate  (1:1,000; Boehringer-Mannheim Bin- 
chemicals) was used. The binding of sheep anti-GAP-43 was detected with 
biotinylated anti-sheep IgG (1:400; Vector Laboratories) followed by either 
strvptavidin-FITC  (1:200; Amersham Corp.) or ABC-phycoerythrin (Vec- 
tor Laboratories). 
This double-immunofluorescence  procedure was carded out using two 
cell type-specific  antigens to distinguish individual macroglial cell types 
and their progenitors.  Bipolar A2B5+,GFAP-; A2BS+,Ran2-; A2BS+,GC  - 
cells were considered to be oligodendrocyte-type  2 astrocyte  (O-2A) pro- 
genitors and bipolar Ran-2+,GFAP-;  Ran-2+,GC-;  Ran-2+,A2B5 -  cells 
were considered to be type 1 astrocyte progenitors (Reffet ai., 1979; Miller 
et al.,  1989).  Ceil  with  many narrow processes,  A2B5+,GFAP  +,  Ran- 
2-,GFAP  + were  considered type 2  astrocytes  and cells with few broad 
processes,  Ran-2+,GFAP+; A2B5-,GFAP  +, type 1 astrocytes  (Raft et al., 
1979; Miller et al.,  1989). GC+,GFAP-;  GC+,Ran-2-; GC+,A2B5 -  cells 
were considered oligodendrocytcs  (Reffet al., 1978). Primary cultures were 
NF-68- and therefore  considered free of neurons (Vitkovi6 et al.,  1988). 
Once individual macroglial cell types were characterized, the double im- 
munofluorescence  procedures  were used to identify cells containing GAP- 
43ir. The method used for staining cultured cells with anti-GAP-43 was that 
published by Meiri et al. (1986),  modified by Vitkovi6 et al. (1988). Cul- 
tures were exposed  to anti-GAP-43  followed by antibody against the cell 
type-specific antigen, followed by fluoresccin-  and rhodamine-conjugated 
secondary antibodies,  respectively.  Cells that were GFAP+,GAP-43  + were 
considered type 1 and type 2 astrocytes  (Bignami et al.,  1972).  Whereas 
type 1 astrocytes and their progenitors were recognized by their cell-specific 
antigen Ran-2, type 2 astrocytes and oligodendmcyte-type  2 astroeyte pro- 
genitors were recognized by antigen A2B5 (Raffet al., 1979; Miller et al., 
1989). Oligndendrocytes  were recognized by their cell specific antigen GC 
(Raft et al.,  1978). In double stainings involving the surface antigens,  and 
membrane associated GAP-43 cells on coverslips were sequentially  surface 
labeled first for either A2B5, Ran-2 or GC, followed by anti-mouse rheda- 
mine, and then GAP-43 was detected as described above. In these experi- 
ments cells that were  rhodamine  + (A2B5  +,  Ran-2 + or GC  +) were easily 
distinguished from cells that were fluorescein + (GAP-43+). 
After immunolabeling, coverslips  were washed and mounted on a drop 
of aqueous mounting medium (Chemicnn International, Inc., Temecula, 
CA). Cells were examined in a Zeiss axioplan microscope equipped with 
phase contrast, epifluorescence,  and rhodamine and fluorescein optics and 
equipped for photography. 
The Journal of Cell Biology, Volume l 11, 1990  210 Figure 1. Cells in primary astrocytic culture do not stain with antibody to 68-kD neurofilament (NF68) but do stain with antibody to GFAP. 
Cells were cultured for 2 days and immunostained with anti-NF68 and anti-GFAP antibodies followed by rhodamine- (red) and FITC- 
conjugated (green) secondary antibodies, respectively. Double exposure photomicrograph is shown (A). Phase-contrast micrograph reveals 
several round NF68-, GFAP- cells, which are probably astrocytic progenitors (B). In contrast, anti-NF68 antibody stained intensely cer- 
ebellar neurons in primary culture (C). Cells were cultured g d and immunostained with anti-NF68 and anti-GAP-43 antibodies followed 
by rhodamine and FITC-conjugated secondary antibodies, respectively. Double-exposure  photomicrograph demonstrates the ease of label- 
ing with anti-NF68 as well as no mutual interference between rhodamine and FITC signals. Note an NF68-, GAP-43  + cell with glial mor- 
phology (arrow,  C).  x186. 
Photomicrography and Quantitation 
The time course of GAP-43ir expression in cultured rat cortical astrocytes 
was assessed immulaocytochemicaUy  as follows: three coverslips were ran- 
domly selected and cells stained with anti-GAP-43 and anti-GFAP followed 
by fluorescein- and rhodamine-conjugated  secondary  antibodies,  respec- 
tively, as described  in "Fixation and ImmunolabelingY Three fields were 
photographed from each coverslip using T-Max 400 (Eastman Kodak Co., 
Rochester, NY) film exposed for 20 s at 1,600 ASA using filters for either 
rhodamine or fluorescein at a magnification of 250. Contact prints such as 
the ones in Fig. 3 were made and cells counted with the aid of  a magnifying 
glass. On the average, 517 cells were counted per time point or from 18 to 
237 per field. The number of GFAP  + cells expressing GAP-43ir were esti- 
mated as percentage of total cells expressing GFAP. The number of oligo- 
dendrocytes expressing GAP-43 was assessed after double immunostaining 
with anti-CrC and anti-GAP-43ir as described  in "Fixation and Immuno- 
labelingY Cells were photographed  as described  above and percent cells 
staining for both GC and GAP-43ir calculated as percent total GC  + cells. 
To determine the expression of GAP-43ir separately in types 1 and 2 astro- 
cytes, ceils were double immunostained with anti-GFAP and either anti- 
A2B5 or anti-Ran-2. The percent A2B5+,GFAP  + with many narrow pro- 
cesses (type 2 astrocytes; Raffet al., 1979; Miller and Raft, 1984; Miller 
et al., 1989) was calculated with reference to the number of Ran-2+,GFAP  + 
cells with few broad processes (type 1 astrocytes; Raft et al.  1979; Miller 
and Raft, 1984; Miller et al., 1989). This ratio of type 1 to type 2 astrocytes 
was compared with values obtained from ceils stained with anti-GFAP and 
anti-GAP-43. Photographs of cells stained with both anti-GFAP and anti- 
GAP-43 were assessed for percent cells that were GFAP  + and having many 
narrow processes  (type 2 astrocytes;  Raft et al.,  1979; Miller and Raft, 
1984; Miller et al.,  1989) as opposed to percent cells that were GFAP  + 
with few broad processes (type 1 astrocytes; Raft et al., 1979; Miller and 
Raft, 1984; Miller et al., 1989). The values obtained for percent type 1 and 
type 2 astrocytes were similar to those obtained using cell type-specific 
markers, Ran-2+/GFAP  + and A2B5+/GFAP  + described above. 
The  number  of astrocytes  per unit  surface  area  was determined  by 
detaching ceils with 0.05 % trypsin (suspended in 0.02 % EDTA in calcium, 
magnesium-free HBSS) at 37°C for 2 min. Viable cells were counted after 
dilution (1:1, vol/vol) in trypan blue (0.4%,  wt/vol). 
Whenever appropriate the results were analyzed by t test. 
Results and Discussion 
Astrocytic cultures used in this study are a well-defined, ho- 
mogeneous population consisting of both types of astrocytes 
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Figure 2. Time course of  GAP-43 expression in cultured rat cortical 
astrocytes assessed immunocytochemicaily.  Number of GAP-43  ÷ 
cells as a fraction of the total GFAP  + cells was plotted against the 
time in culture (e). Data represent an average  and SD of three inde- 
pendent experiments. In one experiment the rabbit and in the other 
two, the sheep anti-GAP-43 antibodies were used. Growth of astro- 
cytes in culture is noted by open circles (o). In each case, the num- 
ber of GFAP  + cells was 95-100% of cells recorded in light phase 
photomicrographs. 
and no neurons (Sensenbrenner et al., 1980; Vitkovid et al., 
1988). The staining of  these cells from culture day 2 onwards 
with anti-NF68, a neuron-specific marker, has been persis- 
tently negative (Fig.  1 A and Vitkovi6  et al.,  1988).  This 
strongly suggests,  although it does not prove, that there are 
no neurons in these cultures. In contrast to astrocytic cul- 
tures,  cerebellar granule neurons in primary culture im- 
munostained reproducibly  and  intensely  with  anti-NF68 
(Fig. 1 C). These cells contained large amounts of GAP-43 
as judged by intense immunostaining with anti-GAP-43  (Fig. 
1 C) as well as assessed by two dimensional PAGE as we 
showed previously (Steisslinger et al., 1987). The pattern of 
immunostaining with anti-NF68 is similar but distinct from 
that observed with anti-GAP-43 (Fig. 1 C). This suggests no 
"bleed through" between rhodamine and FITC filters, which 
is consistent with the manufacturer's specifications. 
Using double immunofluorescence labeling with antibod- 
ies to GFAP as an intracellular marker for astrocytes (Raft 
et al., 1979) and one of the two monospecific antibodies to 
GAP-43 (Benowitz et al., 1988; Skene et al., 1986; Vitkovid 
et al.,  1988),  we counted GAP-43  immunoreactive astro- 
cytes present at various times during development. Results 
obtained with the purified rabbit anti-GAP-43 did not differ 
from  those  obtained  with  the  sheep  anti-GAP-43.  Both 
monospecific  antibodies  to  GAP-43  have  been  demon- 
strated, by multiple criteria, to react specifically with GAP- 
43 (Benowitz et al., 1988; Skene et al., 1986; Vitkovi6 et al., 
1988).  In control experiments we substituted sheep anti- 
GAP-43 with normal sheep serum (diluted 1:500) and found 
no staining of cells. Further, when the sheep anti-GAP-43 
antibody (1/~1) was neutralized with rat GAP-43 protein (5/sg) 
for 30 min at 37°C and then used (1:500 dilution) to stain 
astrocytes, again, no immunostaining was observed (data not 
shown). These results together with those already published 
demonstrate that the anti-GAP-43  antibodies used in these 
studies were specific for GAP-43. 
At 2 d of culture, GAP-43 was present in 80-100% ofas- 
trocytes isolated from 1-d-old cortex. During the ensuing 3 
wk, the number of GAP-43  immunoreactive astrocytes de- 
creased markedly, consistent with our earlier report (Vitko- 
vi6 and Mersel, 1989). The number of GFAP  + cells contain- 
ing GAP-43ir decreased at a linear rate of ~8.4%/d (Fig. 2), 
whereas the amount of GAP-43 protein, as assessed by West- 
ern blotting decreased in a parallel culture at the linear rate 
of --9.1%/d (data not shown). Henc¢~ the amount of GAP-43 
protLfin was proportional to the nunaber  of cells immuno- 
stained for GAP-43  and, thus, to the intensity of immuno- 
fluorescence. Thus, the number and intensity of immunoflu- 
orescence of cells stained with anti-GAP-43 reflected the 
amount of GAP-43  present in these cells. 
Double immunofluorescence labeling of cells with anti- 
GAP-43 and anti-GFAP showed that at 3 d in culture most 
astrocytes stained with both anti-GAP-43  and anti-GFAP. 
Most of these cells looked like type 1 astrocytes, they were 
flat and nonprocess bearing (Fig. 3, A-C). After 8 d, ,x,80% 
of the GFAP  + cells stained weakly and 20% intensely with 
anti-GAP-43.  The weakly stained GAP-43 ÷ cells had type 1 
morphology (Fig. 3, D-F),  whereas those that stained in- 
tensely had type 2  morphology (process  bearing,  Fig.  3, 
D-F).  By day 14 of culture the distinction was even more 
clearly discernible (Fig. 3, G-l). These observations suggest 
that the regulation of GAP-43ir expression in astrocytes is 
cell type specific. 
Using as criteria antiastrocyte  type-specific antibody bind- 
ing (Ran-2 and A2B5; Miller and Raft, 1984) and morphol- 
ogy (Raft et al.,  1979),  we scored type 1 and 2 GFAP  + as- 
trocytes for expression of GAP-43 immunoreactivity. 10-20% 
of GAP-43 immunoreactive astrocytes cultured for 8 d were 
predominantly, if not exclusively, type 2 astrocytes (Fig. 4). 
While the intensity of staining of type 1 astrocytes with anti- 
GAP-43 progressively decreased over 8 d, type 2 astrocytes 
constantly expressed this protein to ages corresponding to 
the adult cortex (Figs.  3 and 4). Because ,~80-90%  of the 
cells in these cultures were type 1 astrocytes, the develop- 
mental pattern of immunoreactive GAP-43  astrocytes de- 
scribed above, and the decrease in GAP-43 protein (Vitkovi6 
and Mersel, 1989) correspond predominantly to type 1. These 
results suggest that GAP-43 is downregulated in type 1 astro- 
cytes and constitutively expressed in type 2 astrocytes. The 
adult rat cerebellum is reported to contain predominantly 
type I astrocytes (Raffet al., 1983) and low levels of GAP-43 
mRNA (Skene et al., 1986), which is consistent with our ob- 
servations. 
Oligodendrocytes and type 2, but not type 1, astrocytes de- 
velop from a common A2B5  ÷ progenitor cell known as the 
bipotential O-2A progenitor (Temple and Raft, 1985; Miller 
et al., 1989; Raft, 1989). Because type 2 astrocytes appeared 
to constitutively express GAP-43ir,  it was of interest to de- 
termine whether oligodendrocytes also express GAP-43ir. 
When oligodendrocytes were exposed to antibodies to their 
cell type marker, GC, and GAP-43, followed by appropriate 
secondary antibodies, the coincidence between the two anti- 
gens was observed (Fig. 5). Both the rabbit and sheep anti- 
GAP-43 antibodies have been found to react specifically with 
rat GAP-43 as demonstrated by multiple criteria (Benowitz 
et al.,  1988;  Skene  et al.,  1986;  Vitkovid  et al.,  1988). 
Oligodendrocytes stained at 9, 11, 22, 23, and 28 d in culture 
were  GAP-43ir  +.  These  results  were  obtained  with  two 
monospecific polyclonal antisera obtained from two inde- 
pendent sources, as described above. The intensity of label- 
ing with anti-GAP-43  was independent of when the cells 
were stained.  This suggests that oligodendrocytes contain 
GAP-43ir and that its expression is independent of time in 
The Journal of Cell Biology, Volume 111,  1990  212 Figure 3. Differential expression of GAP-43ir in two types of astrocytes during development. A fluorescent photomicrograph  of cells 3 d 
in culture stained with anti-GAP-43 (A). The majority of cells were GFAP  + (B) with the morphology of type 1 astrocytes (C). A fluorescent 
photomicrograph of astrocytes 8 d in culture stained with anti-GAP-43 (D). Approximately 80-90% of these cells stained weakly for GAP- 
43, and had the type 1 morphology (E). 10-20% of  the cells intensely stained for GAP-43 (F) and GFAP (E) and had the type 2 morphology 
(F). A fluorescent photomicrograph  of astrocytes stained with anti-GAP-43 after 14 d in culture (G). Approximately  10-20 % of the cells 
intensely stained for GFAP (H) and had the type 2 morphology  (I). The distinct morphology of the two types is clearly visible,  x250. 
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Figure 4. Developmental expression of GAP-43ir differs in the two 
astrocytic cell types. Number of GAP-43  ÷ cells as a fraction of all 
GFAP  + cells  of the  type  1 (o) and  type 2  (o) morphology was 
plotted against the time in culture. In these cultures containing both 
type I and type 2 astrocytes, cells of  the type 2 morphology stained 
A2B5  ÷, GAP-43  +, whereas  type 1 stained A2B5-, Ran-2  +.  Data 
represent an average number of cells and standard deviation from 
three  independent  experiments. 
culture. Thus, the regulation of GAP-43ir expression in oli- 
godendrocytes appears to be constitutive. 
We also wanted to know how early GAP-43ir is expressed 
in the differentiation of each macroglial cell type. To address 
this question we double-stained cells in either astrocytic or 
oligodendrocytic cultures early in development with combi- 
nations  of cell type-specific antibodies.  We observed that 
bipolar Ran-2  + GFAP- and  A2B5 + GFAP- or A2B5 + GC- 
cells characteristic of type 1 and 0-2A progenitors, respec- 
tively (Federoff, 1985; Temple and Raft, 1985), stained very 
intensely  with  anti-GAP-43  antibody,  indicating  that  they 
contained high levels of GAP-43ir (Fig. 6). This result sug- 
gests that GAP-43ir is expressed during the differentiation of 
macroglial progenitors before GFAP in astroeytes and GC in 
oligodendrocytes are expressed. 
The developmental regulation of GAP-43ir expression, the 
hallmark of this protein (Jacobsen et al.,  1986;  Basi et al., 
1987)  may be,  at least in  part,  determined  by macroglial 
differentiation. Increase in GAP-43 during the first postnatal 
da Cunha and Vitkovi6 GAP-43ir Expression in Macroglia  213 Figure 5. Oligodendrocytes express GAP-43ir. Fluorescent photomicrograph of rat cortical cells 23 d in culture stained with anti-GAP-43 
antibody (A) and anti-galactocerebroside  antibody (B), display the oligodendrocyte morphology  (C). 
week (Jacobsen et al.,  1986;  Basi et al.,  1987)  coincides 
with  the  proliferation  of oligodendrocyte type 2  astrocyte 
progenitors in addition to neurons.  Its precipitous decrease 
over the next 2 wk of development coincides with the down- 
regulation observed in type 1 astrocytes. This is supported 
by the observations that brain regions presumed rich in type 
1  astrocytes,  such  as  cerebellum,  express  little  GAP-43 
mRNA in adult rat brain (Raft et al.,  1983;  Oestreicher et 
al., 1986; Neve et al., 1987; Benowitz et al., 1988).  The high 
amounts of GAP-43 that persist in adult brain (Oestreicher 
et al., 1986; Karns et al., 1987; Snipes et al., 1987; Benowitz 
et al.,  1988) may be partly due to constitutive expression of 
GAP-43 in oligodendrocytes and type 2 astrocytes. We have 
also found that granule cells from the cerebellum produce 
high levels of GAP-43 protein (Steisslinger et al.,  1987) and 
their long neurites in culture intensely stain with anti-GAP- 
43 (Fig.  1 C). These macroglial cell types and granule neu- 
rons are process-bearing with large  surface-to-volume ra- 
tios.  In contrast,  type 1 astrocytes in confluent culture are 
polygonal cells without long processes.  Thus,  constitutive 
GAP-43 expression occurs in highly arborescent cells with 
branched  or  unbranched  processes,  and  not  in  cells  with 
small surface-to-volume ratio. It appears as if the number of 
GAP-43 molecules per unit area of membrane may be held 
constant.  This  suggests that  GAP-43  may function during 
differentiation in the synthesis and,  after differentiation,  in 
the maintenance of neural cell processes or neurites.  These 
processes do not have to necessarily form synapses (Goslin 
et  al.,  1988)  but  may  form  nodes  of Ranvier  or  myelin 
sheaths (Miller et al.,  1989;  Raft,  1989).  The observation 
that  three  immortalized,  non-neural  cell  lines  transfected 
with the GAP-43 gene in an expression vector grew long thin 
processes reminiscent of filopodia, supports this view (Zuber 
et al.,  1989). 
After the submission of this manuscript it has come to our 
attention that others have detected GAP-43ir in nonneuronal 
cells. GAP-43ir was detected using one of the two antibodies 
we used, in satellite/Schwann cells in cultured adult rat dor- 
sal root ganglia (Woolf  et al., 1990.) Thus, nonneuronal cells 
of the peripheral nervous system are also capable of express- 
ing GAP-43ir. 
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